Collaboration - April 20, 2016
Nuevolution expands collaboration
Nuevolution has announced that Janssen Biotech, one of the Pharmaceutical Companies of Johnson & Johnson, has used its option to expand the collaboration with Nuevolution, thereby providing Nuevolution with a further payment of 600,000 USD. Nuevolution A/S and Janssen Biotech entered into collaboration on 19 October, 2015 for application of Nuevolution’s proprietary Chemetics drug discovery platform […]
Acquisition - April 21, 2015
Novo Nordisk, Janssen Sign Pact
Novo Nordisk A/S and Janssen Biotech, Inc. have signed an agreement that will allow Janssen to acquire an exclusive global license to further develop and commercialize a clinical program focused on therapy within autoimmune diseases. The program targets modulation of certain immune cells via a cell surface receptor (NKG2D receptor), according to Novo Nordisk. The […]
Collaboration - December 6, 2013
Genmab announces expansion with Janssen Biotech
Genmab have announced an expansion of its collaboration with Janssen Biotech to create and develop bispecific antibodies using the DuoBody technology platform. The original agreement entitled Janssen to work on up to ten DuoBody programs. Under the terms of the amendment, Janssen is entitled to work on up to ten additional programs. Genmab will receive […]
